Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00042211 · ClinicalTrials.gov registry record · Phase 3
Preventing Depression in Patients With Macular Degeneration
A Phase 3 study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Phase 3
- Development phase
- 206
- Enrollment target
NCT00042211 is a Phase 3 study that has completed, run by Thomas Jefferson University. The registered enrollment target is 206 participants.
The verdict
NCT00042211, a Phase 3 study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 206 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of a Problem Solving Treatment in preventing depression in elderly patients with age-related macular degeneration (AMD).
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Problem Solving Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2001-02 |
| Est. Completion | 2006-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00042211
The ClinicalTrials.gov registry entry for NCT00042211 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT00042211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00042211 about?
NCT00042211 is a clinical study titled "Preventing Depression in Patients With Macular Degeneration". This study will evaluate the effectiveness of a Problem Solving Treatment in preventing depression in elderly patients with age-related macular degeneration (AMD).
What is the current status of trial NCT00042211?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 206 participants. The study started on 2001-02. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00042211?
The interventions under investigation include: Control (BEHAVIORAL), Problem Solving Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00042211?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.